Search results for “Cd38 expression” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 42 patents, we discovered top 15 key players by total patent application. Research Development Foundation, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., MorphoSys AG are dominant in this area. They take 35.71% of the total patent filing.
Research Development Foundation
United States
Patent: 8
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 4
MorphoSys AG
Bayern, Germany
Patent: 3
Jiangsu Kanion Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Genmab A/S
Hovedstaden, Denmark
Patent: 3
Intervene Immune, Inc.
California, United States
Patent: 3
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 3
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.
Shanghai Shi, China
Patent: 2
AcroImmune BioTech. Co., Ltd
Guangdong Sheng, China
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 22 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Intervene Immune, Inc., Jiangsu Kanion Pharmaceutical Co., Ltd. take 45.45% of patent filing during this period.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 4
Intervene Immune, Inc.
California, United States
Patent: 3
Jiangsu Kanion Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.
Shanghai Shi, China
Patent: 2
AcroImmune BioTech. Co., Ltd
Guangdong Sheng, China
Patent: 2
Peking University First Hospital
Beijing Shi, China
Patent: 1
SuZhou Stainwei Biotech Inc.
Jiangsu Sheng, China
Patent: 1
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 22 patents in last 5 years, we discover 7 new entrants. Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Intervene Immune, Inc., Jiangsu Kanion Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 4
Intervene Immune, Inc.
California, United States
Patent: 3
Jiangsu Kanion Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd.
Shanghai Shi, China
Patent: 2
AcroImmune BioTech. Co., Ltd
Guangdong Sheng, China
Patent: 2
Peking University First Hospital
Beijing Shi, China
Patent: 1
SuZhou Stainwei Biotech Inc.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: